查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1806361

透析机市场按可重复使用类型、通量类型、膜材料、灭菌方法、疾病类型、病患小组、应用、最终用户和销售管道划分 - 全球预测 2025-2030

Dialyzer Market by Reuse Type, Flux Type, Membrane Material, Sterilization Method, Disease Type, Patient Group, Application, End User, Sales Channel - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 198 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2024 年透析设备市场价值为 65 亿美元，预计 2025 年将成长至 68.8 亿美元，复合年增长率为 6.24%，预计到 2030 年将达到 93.5 亿美元。

主要市场统计数据
基准年2024年 65亿美元
预计2025年 68.8亿美元
预测年份 2030 93.5亿美元
复合年增长率（%） 6.24%

透过将临床表现、供应关係和护理设定优先顺序与策略决策联繫起来，了解当前透析器的情况

透析器在肾臟替代疗法中发挥着至关重要的作用，它直接连接着患者的生理机能和更广泛的医疗保健服务系统。透析膜化学、灭菌过程和临床通讯协定的进步正在改变医疗服务提供者选择用于急性和慢性肾臟护理的透析器的方式，而人们对以患者为中心的环境（例如家庭透析治疗）日益增长的兴趣也改变了透析器的采购重点。如今，临床医生、医院管理人员和居家照护协调员在选择透析器技术时，需要权衡临床表现、生物相容性、易用性和总服务成本。

膜化学、灭菌技术和护理模式的同步进步如何改变透析器产品设计和采购选择

透析器领域正在经历重大变革，这得益于材料科学的进步、医疗保健服务偏好以及强调安全性和无菌性的监管环境。改良的合成膜技术透过卓越的溶质清除特性和更低的发炎反应影响着临床医师的选择。同时，家庭透析治疗的日益普及也推动着异地应用的设计变革，强调紧凑性、易于操作和强大的抗灭菌性。

评估2025年美国关税调整如何重塑透析器相关人员的供应链、采购决策和采购风险

改变2025年美国关税结构的政策措施，给服务透析供应商、设备製造商和耗材供应商的整个供应链带来了巨大压力。某些进口零件和成品关税的提高，增加了依赖海外供应商的组织的成本基础，促使采购团队重新评估其筹资策略和库存缓衝。长期依赖进口的价值链上的公司面临日益加剧的物流复杂性和短期成本波动，因此需要更严格的供应商风险评估和重新谈判合约条款。

将再利用、通量、膜化学、灭菌、临床应用、病患小组和分销联繫起来形成可操作策略的多维细分框架

透过对产品和客户细分的详细了解，可以清楚地了解临床需求、製造复杂性和灭菌实践之间的交集。根据重复使用类型，市场涵盖可重复使用和一次性设备，这些设备会影响灭菌通讯协定、资本规划和感染预防措施。根据通量类型，市场涵盖高通量和低通量，反映了对临床适应症和清除性能的考虑。根据膜材料，市场涵盖纤维素和合成材料，其中纤维素涵盖醋酸纤维素和再生纤维素，合成材料涵盖聚酰胺、聚醚砜和聚砜。

美洲、欧洲、中东和非洲以及亚太地区的区域动态将决定采购行为、临床采用和生产在地化选择

区域动态对供应策略、临床应用和创新路径有重大影响。在美洲，重视与大型透析网路的整合、遵守国家和地区主管部门的监管规定以及采用居家照护模式，这些因素会影响采购週期、对可扩展灭菌能力的需求以及与肾臟护理平台互通性的要求。在欧洲、中东和非洲，国家采购框架、多样化的报销模式和不同的临床指南呈现出差异化的格局，从而形成了区域特定的产品偏好。在该地区运作的组织必须在中央监管格局与尊重国家层面细微差别的弹性服务模式之间取得平衡。

材料创新者、设备製造商、灭菌专家和服务合作伙伴如何透过技术、证据和供应可靠性创造竞争优势

透析器生态系统的竞争格局由材料创新者、设备製造商、灭菌专家以及支援培训和持续供应的服务型供应商共同构成。领先的製造商通常凭藉膜技术和临床证据脱颖而出，投资材料工程以优化溶质清除率和生物相容性，同时培养服务能力，以减少医院和居家医疗护理机构之间的摩擦。能够展示一致的灭菌工艺、可靠的供应链以及强大的临床医生参与计划以支持其应用的公司将获得巨大的价值。

製造商和医疗保健提供者可以采取切实可行的措施来增强供应弹性，加速临床检验，并使产品系列与不断发展的护理环境保持一致

产业领导者应立即采取切实可行的措施，保障临床的连续性，优化采购弹性，并使产品开发与不断发展的医疗模式保持一致。首先，优先考虑关键膜材料和灭菌投入的双源或近源策略，以减少单一来源的风险，同时协商灵活的条款以应对供应波动。其次，加速临床证据项目，阐明不同膜类型和通量配置在关键适应症的比较结果。第三，投资灭菌伙伴关係或有效的灭菌合同，以减少前置作业时间的波动，并为一次性和可重复使用途径提供可扩展的产能。

采用混合方法研究途径，结合临床医生访谈、采购见解、材料科学文献和监管协调，以获取检验的行业信息

本执行摘要所依据的研究整合了多个定性和定量资讯来源，以确保结果均衡检验。主要输入包括对急慢性肾臟病护理机构的临床医生、透析中心和医院的采购负责人以及设备和膜供应商的产品经理进行的结构化访谈。次要输入包括关于膜生物相容性和灭菌效果的同行评审文献、详细说明灭菌验证要求的监管指导文件，以及与医疗设备分销相关的供应链业务分析。

整合临床、业务和政策因素，明确优先考虑透析照护中的产品完整性、供应弹性和实证采用。

累积分析表明，透析器策略必须多维度考虑，同时考虑膜技术、灭菌途径、临床应用和分销机制。随着政策变化和供应中断改变采购计算，营运韧性正成为一项竞争优势。能够将材料性能与应用需求相结合，同时透过有效灭菌和灵活采购最大限度地降低物流复杂性的产品系列，最有利于维护临床医生的信任和采购偏好。

目录

第一章：前言

第二章调查方法

第三章执行摘要

第四章 市场概述

第五章市场动态

  • 引入生物相容性聚合物涂层以减少慢性肾臟病病患者透析器引起的炎症
  • 扩展可携式和可穿戴血液透析机设备，以实现家庭治疗并提高患者的独立性
  • 将机器学习演算法整合到透析设备中，以即时优化性能和患者安全
  • 透过开发采用先进膜材料的高流量、高效透析设备来提高溶质清除率
  • 采用永续製造流程和可回收材料来解决环境问题
  • 在高级肾臟护理中，使用客製化透析器的线上血液透析机越来越受到青睐，以实现最佳的液体和毒素清除
  • 远端监控和远端医疗平台整合到透析系统中，用于主动管理患者并减少门诊就诊次数

第六章 市场洞察

  • 波特五力分析
  • PESTEL分析

第七章 2025年美国关税的累积影响

第八章 透析机市场（依重复使用类型）

  • 可重复使用的
  • 一次性的

第九章 透析机市场（依通量类型）

  • 高通量
  • 低通量

第 10 章透析机市场（按膜材料）

  • 纤维素
    • 醋酸纤维素
    • 再生纤维素
  • 合成
    • 聚酰胺
    • 聚醚砜
    • 聚砜

第11章透析器市场按灭菌方法

  • 电子束
  • 环氧乙烷
  • 伽玛射线照射
  • 蒸气

第十二章透析机市场（依疾病类型）

  • 急性肾损伤
  • 慢性肾臟病

第十三章 透析机市场病患小组

  • 成人
  • 老年人
  • 小儿科

第十四章 透析机市场：依应用

  • 血液透析机
  • 血液透析机
  • 血液过滤
  • 腹膜透析
  • 血浆置换

第十五章透析机市场（依最终用户）

  • 透析中心
  • 居家照护环境
  • 医院

第十六章 透析机市场按销售管道

  • 离线
  • 在线的

第 17 章：美洲透析机市场

  • 美国
  • 加拿大
  • 墨西哥
  • 巴西
  • 阿根廷

第18章：欧洲、中东和非洲透析机市场

  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 阿拉伯聯合大公国
  • 沙乌地阿拉伯
  • 南非
  • 丹麦
  • 荷兰
  • 卡达
  • 芬兰
  • 瑞典
  • 奈及利亚
  • 埃及
  • 土耳其
  • 以色列
  • 挪威
  • 波兰
  • 瑞士

19. 亚太透析机市场

  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国
  • 印尼
  • 泰国
  • 菲律宾
  • 马来西亚
  • 新加坡
  • 越南
  • 台湾

第二十章 竞争格局

  • 2024年市场占有率分析
  • 2024年FPNV定位矩阵
  • 竞争分析
    • Advin Health Care
    • B. Braun SE
    • Allmed Medical Care Holdings Limited
    • AntiTeck Life Sciences Limited
    • Asahi Kasei Corporation
    • BAIN MEDICAL EQUIPMENT（GUANGZHOU）CO.,LTD
    • Baxter International, Inc.
    • BenQ Dialysis Technology Corp.
    • Browndove Healthcare Private Limited
    • Dialife SA
    • Edges Medicare Private Limited.
    • Farmasol
    • Fresenius Medical Care AG
    • Hemant Surgical Industries Ltd.
    • JiangXi Sanxin Medtec Co.,Ltd.
    • JMS Co., Ltd.
    • Kaneka Corporation
    • Lepu Medical Technology（Beijing）Co.,Ltd.
    • Medica SPA
    • Merck KGaA
    • Mozarc Medical Holdings LLC
    • NephroCan group
    • Nikkiso Co., Ltd.
    • Nipro Corporation
    • Pollet Medical Group
    • Poly Medicure Ltd.
    • SHENZHEN ALL TRUSTED MEDICAL CO., LTD
    • Shinva Medical Instrument Co., Ltd.
    • STERIS plc
    • Sumitomo Bakelite Co., Ltd.
    • SUNFORD HEALTHCARE PRIVATE LIMITED
    • Toray Industries, Inc.
    • VJ Industries
    • Vivance
    • WEIGAO GROUP

第21章 研究人工智慧

第22章 研究统计

第23章 研究联络人

第24章 研究报导

第25章 附录

Product Code: MRR-4348D129FA20

The Dialyzer Market was valued at USD 6.50 billion in 2024 and is projected to grow to USD 6.88 billion in 2025, with a CAGR of 6.24%, reaching USD 9.35 billion by 2030.

KEY MARKET STATISTICS
Base Year [2024] USD 6.50 billion
Estimated Year [2025] USD 6.88 billion
Forecast Year [2030] USD 9.35 billion
CAGR (%) 6.24%

Contextualizing the present dialyzer landscape by linking clinical performance, supply relationships, and care-setting priorities to strategic decision-making

Dialyzers occupy a pivotal role within renal replacement therapy, interfacing directly between patient physiology and the broader healthcare delivery system. Advances in membrane chemistry, sterilization processes, and clinical protocols have changed how providers select devices for acute and chronic renal care, while increasing attention to patient-centric settings such as home dialysis has reshaped procurement priorities. Clinicians, hospital administrators, and homecare coordinators now balance clinical performance, biocompatibility, ease of use, and total cost of service when choosing dialyzer technologies.

Moreover, the interplay between device manufacturers and support-service providers has become more integrated, with collaborations that align membrane design to consumables, sterilization standards, and training programs. Regulatory scrutiny on safety and sterilization, coupled with evolving reimbursement and procurement practices, has elevated the importance of demonstrable clinical outcomes and operational efficiencies. As a result, stakeholders are placing greater value on evidence generation, clinical partnerships, and product portfolios that accommodate diverse patient groups and care settings. These dynamics frame the fundamentals for strategic decision-making and operational prioritization across the dialyzer ecosystem.

How concurrent advances in membrane chemistry, sterilization technology, and care-delivery models are reshaping dialyzer product design and procurement choices

The dialyzer landscape is undergoing transformative shifts driven by concurrent advances in materials science, care delivery preferences, and regulatory emphasis on safety and sterilization. Improvements in synthetic membrane technologies are influencing clinician choice through superior solute clearance profiles and reduced inflammatory response, while refinements in cellulose modifications remain relevant where compatibility and cost considerations are prioritized. At the same time, the rising acceptability of home-based dialysis modalities is prompting design changes that favor compactness, ease of handling, and robust sterilization resilience for products used outside institutional environments.

Concurrently, sterilization method evolution is shaping supplier selection criteria; gamma and electron-beam sterilization offer differing throughput and logistics trade-offs compared with ethylene oxide and steam processes, affecting lead times and distribution planning. High-flux dialysis has gained traction for specific clinical indications, prompting suppliers to curate portfolios that span both high and low flux performance. These technical shifts are accompanied by commercial realignments, with manufacturers concentrating on integrated solutions that pair membrane innovation with consumables and service frameworks to bolster clinical adoption and simplify procurement decisions.

Assessing how tariff adjustments implemented in the United States during 2025 have reconfigured supply chains, sourcing decisions, and procurement risk for dialyzer stakeholders

Policy actions altering tariff structures in the United States during 2025 have exerted notable pressure across supply chains that service dialysis providers, device manufacturers, and consumable suppliers. Increased duties on certain imported components and finished products raised the cost base for organizations reliant on international suppliers, prompting procurement teams to re-evaluate sourcing strategies and inventory buffers. Those exposed to long, import-dependent value chains faced amplified logistical complexity and short-term cost variability, necessitating more rigorous supplier risk assessments and renegotiation of contractual terms.

In response, some manufacturers have accelerated localization of critical production steps, prioritized dual sourcing for key membrane components, and intensified collaboration with sterilization vendors to stabilize throughput. Payers and providers seeking to preserve access to essential therapies confronted trade-offs between immediate procurement cost increases and clinical continuity, and in many cases engaged in dialogue with suppliers on pricing structures and service-level agreements. Regulatory and compliance teams also devoted more attention to the provenance of raw materials and sterilization certification, because supply disruptions and tariff-driven cost pressures can cascade into procurement substitutions that have clinical and operational implications.

A multidimensional segmentation framework that links reuse, flux, membrane chemistry, sterilization, clinical application, patient group, and distribution to practical strategy

A granular view of product and customer segments clarifies where clinical need, manufacturing complexity, and sterilization practices intersect. Based on Reuse Type, the market is studied across Reusable and Single-Use, which has implications for sterilization protocols, capital planning, and infection prevention practice. Based on Flux Type, the market is studied across High Flux and Low Flux, reflecting distinct clinical indications and clearance performance considerations. Based on Membrane Material, the market is studied across Cellulose and Synthetic, with Cellulose further studied across Acetate Cellulose and Regenerated Cellulose and Synthetic further examined across Polyamide, Polyethersulfone, and Polysulfone, each material presenting trade-offs in biocompatibility, manufacturing complexity, and cost of goods.

Based on Sterilization Method, the market is studied across Electron Beam, Ethylene Oxide, Gamma Irradiation, and Steam, and sterilization choice affects supply-chain lead times, regulatory documentation, and shelf-life parameters. Based on Disease Type, the market is studied across Acute Kidney Injury and Chronic Kidney Disease, guiding product selection toward intermittent high-clearance or long-term biocompatibility profiles. Based on Patient Group, the market is studied across Adult, Geriatric, and Pediatric populations, which drives sizing, membrane pore design, and training needs. Based on Application, the market is studied across Hemodiafiltration, Hemodialysis, Hemofiltration, Peritoneal Dialysis, and Plasmapheresis, each application imposing specific performance requirements. Based on End User, the market is studied across Dialysis Centers, Home Care Settings, and Hospitals, shaping packaging, labeling, and service offerings. Finally, based on Sales Channel, the market is studied across Offline and Online distribution routes, with each channel influencing purchasing behavior, stocking models, and customer engagement strategies.

Synthesizing these segmentation lenses reveals intersections where product development and commercial focus yield disproportionate clinical or operational benefit. For example, synthetic membranes optimized for high-flux performance and compatible with rapid sterilization workflows align with hospital acute-care needs, whereas single-use, user-friendly designs that pair with simplified sterilization and remote training resonate more strongly with home care adoption. Understanding how each segmentation axis interacts supports prioritization of R&D investments, channel strategies, and lifecycle management activities.

Regional dynamics across the Americas, Europe, Middle East & Africa, and Asia-Pacific that determine procurement behavior, clinical adoption, and production localization choices

Regional dynamics exert a strong influence on supply strategies, clinical adoption, and innovation pathways. In the Americas, emphasis is frequently placed on integration with large dialysis networks, regulatory compliance with national and regional authorities, and adoption of home-based care models, which together influence purchasing cycles, demand for scaleable sterilization capacity, and requirements for interoperability with renal care platforms. Europe, Middle East & Africa presents a heterogeneous landscape where national procurement frameworks, varied reimbursement models, and differing clinical guidelines produce localized product preferences; organizations operating here must balance central regulatory alignment with flexible service models that respect country-level nuances.

Asia-Pacific is characterized by a combination of rapid infrastructure investment in clinical care, growing prevalence of chronic kidney disease in aging populations, and an expanding domestic manufacturing base. These factors drive both demand for cost-effective solutions and opportunities for manufacturers to localize production or co-develop materials with regional partners. Across all regions, logistics resilience, regulatory harmonization, and clinician education remain pivotal, and cross-regional learning is accelerating as manufacturers and providers adapt best practices from diverse care environments.

How material innovators, device manufacturers, sterilization specialists, and service partners are shaping competitive advantage through technology, evidence, and supply reliability

Competitive dynamics in the dialyzer ecosystem are defined by a mix of material innovators, device manufacturers, sterilization specialists, and service-oriented providers that support training and supply continuity. Leading manufacturers typically differentiate on membrane technology and clinical evidence, investing in materials engineering to optimize solute clearance and biocompatibility, and in parallel, they cultivate service capabilities that reduce friction for hospitals and homecare providers. Substantial value accrues to companies that can demonstrate consistent sterilization processes, supply-chain reliability, and strong clinician engagement programs that support adoption.

Partnerships and contracting arrangements shape the commercial landscape; companies that integrate consumables with training and remote support lower the operational burden for end users and are therefore positioned favorably in procurement discussions. At the same time, niche material suppliers-specialists in polyethersulfone or polyamide formulations-can command strategic importance by enabling higher-performance products. Providers and procurement leaders are increasingly scrutinizing total cost of ownership, device interoperability, and service responsiveness, creating opportunities for agile suppliers to capture preference through demonstrable operational and clinical improvements. Finally, manufacturers that align quality management systems with evolving sterilization standards and that clearly document traceability enhance trust among institutional buyers.

Actionable measures for manufacturers and providers to harden supply resilience, accelerate clinical validation, and align product portfolios with care-setting evolution

Industry leaders should take immediate, pragmatic steps to protect clinical continuity, optimize sourcing resilience, and align product development with evolving care models. First, prioritize dual or near-sourcing strategies for critical membrane materials and sterilization inputs to reduce single-source exposure while negotiating flexible terms that recognize supply volatility. Second, accelerate clinical evidence programs that articulate comparative outcomes for membrane types and flux configurations across primary indications, because demonstrable performance supports uptake in both institutional and homecare settings. Third, invest in sterilization partnerships or validated contract sterilization arrangements that reduce lead-time variability and offer scalable capacity for single-use and reusable pathways.

Additionally, tailor product portfolios to patient-group needs by modularizing design choices for adult, geriatric, and pediatric populations and by offering clear guidance on application-specific selection across hemodialysis, hemodiafiltration, and other therapies. Commercial teams should refine channel strategies to support both offline purchasing through established distributors and online ordering models that facilitate rapid replenishment for homecare users. Finally, develop cross-functional playbooks that link regulatory, clinical, and supply teams to rapidly respond to policy shifts or procurement disruptions, ensuring decisions are evidence-based and operationally executable.

A mixed-method research approach combining clinician interviews, procurement insights, material science literature, and regulatory alignment to produce verifiable industry intelligence

The research underpinning this executive summary integrates multiple qualitative and quantitative sources to ensure a balanced, verifiable result. Primary inputs included structured interviews with clinicians across acute and chronic renal care settings, procurement officers from dialysis centers and hospitals, and product managers at device and membrane suppliers. Secondary inputs comprised peer-reviewed literature on membrane biocompatibility and sterilization efficacy, regulatory guidance documents detailing sterilization validation requirements, and operational analyses of supply-chain practices relevant to medical device distribution.

Data synthesis involved mapping clinical indications to device performance characteristics, cross-referencing sterilization method attributes with logistics and regulatory implications, and triangulating stakeholder perspectives to surface practical adoption barriers and enablers. Analysis prioritized transparency in assumptions, documentation of source provenance, and the use of sensitivity checks where input data exhibited variance. This mixed-method approach supports robust interpretation of clinical and commercial dynamics without reliance on single-source estimates, and it enables the production of actionable insights tailored to operational and strategic decision-making.

Synthesis of clinical, operational, and policy drivers showing clear priorities for product alignment, supply resilience, and evidence-based adoption in dialysis care

The cumulative analysis highlights that dialyzer strategy must be multidimensional, accounting simultaneously for membrane technology, sterilization pathways, clinical application, and distribution mechanics. Operational resilience is increasingly a competitive differentiator as policy shifts and supply interruptions alter procurement calculus. Product portfolios that align material performance to application-specific needs, while also minimizing logistical complexity through validated sterilization and flexible sourcing, are best positioned to maintain clinician trust and procurement preference.

Decision-makers should view current conditions as an inflection point: the intersection of improved membrane science, evolving care models, and heightened supply-chain scrutiny creates windows for innovation and operational refinement. Organizations that translate these insights into concrete programs-whether investing in clinical evidence generation, diversifying sourcing, or streamlining channels for homecare-will be better placed to preserve clinical continuity and seize opportunities as care delivery evolves. Sustained focus on traceability, sterilization validation, and clinician outcomes will remain central to long-term success.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. Market Sizing & Forecasting

5. Market Dynamics

  • 5.1. Implementation of biocompatible polymer coatings to reduce dialyzer-induced inflammation in chronic kidney disease patients
  • 5.2. Expansion of portable and wearable hemodialysis devices enabling home therapy and increased patient autonomy
  • 5.3. Incorporation of machine-learning algorithms in dialysis machines for real-time optimization of dialyzer performance and patient safety
  • 5.4. Development of high-flux, high-efficiency dialyzers using advanced membrane materials to improve solute clearance
  • 5.5. Adoption of sustainable dialyzer manufacturing processes and recyclable materials to address environmental concerns
  • 5.6. Increasing preference for online hemodiafiltration with tailored dialyzers for optimal fluid and toxin removal in advanced renal care
  • 5.7. Integration of remote monitoring and telemedicine platforms with dialyzer systems for proactive patient management and reduced hospital visits

6. Market Insights

  • 6.1. Porter's Five Forces Analysis
  • 6.2. PESTLE Analysis

7. Cumulative Impact of United States Tariffs 2025

8. Dialyzer Market, by Reuse Type

  • 8.1. Introduction
  • 8.2. Reusable
  • 8.3. Single-Use

9. Dialyzer Market, by Flux Type

  • 9.1. Introduction
  • 9.2. High Flux
  • 9.3. Low Flux

10. Dialyzer Market, by Membrane Material

  • 10.1. Introduction
  • 10.2. Cellulose
    • 10.2.1. Acetate Cellulose
    • 10.2.2. Regenerated Cellulose
  • 10.3. Synthetic
    • 10.3.1. Polyamide
    • 10.3.2. Polyethersulfone
    • 10.3.3. Polysulfone

11. Dialyzer Market, by Sterilization Method

  • 11.1. Introduction
  • 11.2. Electron Beam
  • 11.3. Ethylene Oxide
  • 11.4. Gamma Irradiation
  • 11.5. Steam

12. Dialyzer Market, by Disease Type

  • 12.1. Introduction
  • 12.2. Acute Kidney Injury
  • 12.3. Chronic Kidney Disease

13. Dialyzer Market, by Patient Group

  • 13.1. Introduction
  • 13.2. Adult
  • 13.3. Geriatric
  • 13.4. Pediatric

14. Dialyzer Market, by Application

  • 14.1. Introduction
  • 14.2. Hemodiafiltration
  • 14.3. Hemodialysis
  • 14.4. Hemofiltration
  • 14.5. Peritoneal Dialysis
  • 14.6. Plasmapheresis

15. Dialyzer Market, by End User

  • 15.1. Introduction
  • 15.2. Dialysis Centers
  • 15.3. Home Care Settings
  • 15.4. Hospitals

16. Dialyzer Market, by Sales Channel

  • 16.1. Introduction
  • 16.2. Offline
  • 16.3. Online

17. Americas Dialyzer Market

  • 17.1. Introduction
  • 17.2. United States
  • 17.3. Canada
  • 17.4. Mexico
  • 17.5. Brazil
  • 17.6. Argentina

18. Europe, Middle East & Africa Dialyzer Market

  • 18.1. Introduction
  • 18.2. United Kingdom
  • 18.3. Germany
  • 18.4. France
  • 18.5. Russia
  • 18.6. Italy
  • 18.7. Spain
  • 18.8. United Arab Emirates
  • 18.9. Saudi Arabia
  • 18.10. South Africa
  • 18.11. Denmark
  • 18.12. Netherlands
  • 18.13. Qatar
  • 18.14. Finland
  • 18.15. Sweden
  • 18.16. Nigeria
  • 18.17. Egypt
  • 18.18. Turkey
  • 18.19. Israel
  • 18.20. Norway
  • 18.21. Poland
  • 18.22. Switzerland

19. Asia-Pacific Dialyzer Market

  • 19.1. Introduction
  • 19.2. China
  • 19.3. India
  • 19.4. Japan
  • 19.5. Australia
  • 19.6. South Korea
  • 19.7. Indonesia
  • 19.8. Thailand
  • 19.9. Philippines
  • 19.10. Malaysia
  • 19.11. Singapore
  • 19.12. Vietnam
  • 19.13. Taiwan

20. Competitive Landscape

  • 20.1. Market Share Analysis, 2024
  • 20.2. FPNV Positioning Matrix, 2024
  • 20.3. Competitive Analysis
    • 20.3.1. Advin Health Care
    • 20.3.2. B. Braun SE
    • 20.3.3. Allmed Medical Care Holdings Limited
    • 20.3.4. AntiTeck Life Sciences Limited
    • 20.3.5. Asahi Kasei Corporation
    • 20.3.6. BAIN MEDICAL EQUIPMENT(GUANGZHOU)CO.,LTD
    • 20.3.7. Baxter International, Inc.
    • 20.3.8. BenQ Dialysis Technology Corp.
    • 20.3.9. Browndove Healthcare Private Limited
    • 20.3.10. Dialife SA
    • 20.3.11. Edges Medicare Private Limited.
    • 20.3.12. Farmasol
    • 20.3.13. Fresenius Medical Care AG
    • 20.3.14. Hemant Surgical Industries Ltd.
    • 20.3.15. JiangXi Sanxin Medtec Co.,Ltd.
    • 20.3.16. JMS Co., Ltd.
    • 20.3.17. Kaneka Corporation
    • 20.3.18. Lepu Medical Technology(Beijing)Co.,Ltd.
    • 20.3.19. Medica SPA
    • 20.3.20. Merck KGaA
    • 20.3.21. Mozarc Medical Holdings LLC
    • 20.3.22. NephroCan group
    • 20.3.23. Nikkiso Co., Ltd.
    • 20.3.24. Nipro Corporation
    • 20.3.25. Pollet Medical Group
    • 20.3.26. Poly Medicure Ltd.
    • 20.3.27. SHENZHEN ALL TRUSTED MEDICAL CO., LTD
    • 20.3.28. Shinva Medical Instrument Co., Ltd.
    • 20.3.29. STERIS plc
    • 20.3.30. Sumitomo Bakelite Co., Ltd.
    • 20.3.31. SUNFORD HEALTHCARE PRIVATE LIMITED
    • 20.3.32. Toray Industries, Inc.
    • 20.3.33. V J Industries
    • 20.3.34. Vivance
    • 20.3.35. WEIGAO GROUP

21. ResearchAI

22. ResearchStatistics

23. ResearchContacts

24. ResearchArticles

25. Appendix

LIST OF FIGURES

  • FIGURE 1. DIALYZER MARKET RESEARCH PROCESS
  • FIGURE 2. GLOBAL DIALYZER MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 3. GLOBAL DIALYZER MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 4. GLOBAL DIALYZER MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL DIALYZER MARKET SIZE, BY REUSE TYPE, 2024 VS 2030 (%)
  • FIGURE 6. GLOBAL DIALYZER MARKET SIZE, BY REUSE TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 7. GLOBAL DIALYZER MARKET SIZE, BY FLUX TYPE, 2024 VS 2030 (%)
  • FIGURE 8. GLOBAL DIALYZER MARKET SIZE, BY FLUX TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 9. GLOBAL DIALYZER MARKET SIZE, BY MEMBRANE MATERIAL, 2024 VS 2030 (%)
  • FIGURE 10. GLOBAL DIALYZER MARKET SIZE, BY MEMBRANE MATERIAL, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 11. GLOBAL DIALYZER MARKET SIZE, BY STERILIZATION METHOD, 2024 VS 2030 (%)
  • FIGURE 12. GLOBAL DIALYZER MARKET SIZE, BY STERILIZATION METHOD, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 13. GLOBAL DIALYZER MARKET SIZE, BY DISEASE TYPE, 2024 VS 2030 (%)
  • FIGURE 14. GLOBAL DIALYZER MARKET SIZE, BY DISEASE TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 15. GLOBAL DIALYZER MARKET SIZE, BY PATIENT GROUP, 2024 VS 2030 (%)
  • FIGURE 16. GLOBAL DIALYZER MARKET SIZE, BY PATIENT GROUP, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 17. GLOBAL DIALYZER MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
  • FIGURE 18. GLOBAL DIALYZER MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 19. GLOBAL DIALYZER MARKET SIZE, BY END USER, 2024 VS 2030 (%)
  • FIGURE 20. GLOBAL DIALYZER MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 21. GLOBAL DIALYZER MARKET SIZE, BY SALES CHANNEL, 2024 VS 2030 (%)
  • FIGURE 22. GLOBAL DIALYZER MARKET SIZE, BY SALES CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 23. AMERICAS DIALYZER MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 24. AMERICAS DIALYZER MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 25. UNITED STATES DIALYZER MARKET SIZE, BY STATE, 2024 VS 2030 (%)
  • FIGURE 26. UNITED STATES DIALYZER MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 27. EUROPE, MIDDLE EAST & AFRICA DIALYZER MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 28. EUROPE, MIDDLE EAST & AFRICA DIALYZER MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 29. ASIA-PACIFIC DIALYZER MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 30. ASIA-PACIFIC DIALYZER MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 31. DIALYZER MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 32. DIALYZER MARKET, FPNV POSITIONING MATRIX, 2024
  • FIGURE 33. DIALYZER MARKET: RESEARCHAI
  • FIGURE 34. DIALYZER MARKET: RESEARCHSTATISTICS
  • FIGURE 35. DIALYZER MARKET: RESEARCHCONTACTS
  • FIGURE 36. DIALYZER MARKET: RESEARCHARTICLES

LIST OF TABLES

  • TABLE 1. DIALYZER MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL DIALYZER MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL DIALYZER MARKET SIZE, 2025-2030 (USD MILLION)
  • TABLE 5. GLOBAL DIALYZER MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL DIALYZER MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 7. GLOBAL DIALYZER MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL DIALYZER MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
  • TABLE 9. GLOBAL DIALYZER MARKET SIZE, BY REUSE TYPE, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL DIALYZER MARKET SIZE, BY REUSE TYPE, 2025-2030 (USD MILLION)
  • TABLE 11. GLOBAL DIALYZER MARKET SIZE, BY REUSABLE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL DIALYZER MARKET SIZE, BY REUSABLE, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 13. GLOBAL DIALYZER MARKET SIZE, BY SINGLE-USE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL DIALYZER MARKET SIZE, BY SINGLE-USE, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 15. GLOBAL DIALYZER MARKET SIZE, BY FLUX TYPE, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL DIALYZER MARKET SIZE, BY FLUX TYPE, 2025-2030 (USD MILLION)
  • TABLE 17. GLOBAL DIALYZER MARKET SIZE, BY HIGH FLUX, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL DIALYZER MARKET SIZE, BY HIGH FLUX, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 19. GLOBAL DIALYZER MARKET SIZE, BY LOW FLUX, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL DIALYZER MARKET SIZE, BY LOW FLUX, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 21. GLOBAL DIALYZER MARKET SIZE, BY MEMBRANE MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL DIALYZER MARKET SIZE, BY MEMBRANE MATERIAL, 2025-2030 (USD MILLION)
  • TABLE 23. GLOBAL DIALYZER MARKET SIZE, BY CELLULOSE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL DIALYZER MARKET SIZE, BY CELLULOSE, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 25. GLOBAL DIALYZER MARKET SIZE, BY ACETATE CELLULOSE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL DIALYZER MARKET SIZE, BY ACETATE CELLULOSE, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 27. GLOBAL DIALYZER MARKET SIZE, BY REGENERATED CELLULOSE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL DIALYZER MARKET SIZE, BY REGENERATED CELLULOSE, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 29. GLOBAL DIALYZER MARKET SIZE, BY CELLULOSE, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL DIALYZER MARKET SIZE, BY CELLULOSE, 2025-2030 (USD MILLION)
  • TABLE 31. GLOBAL DIALYZER MARKET SIZE, BY SYNTHETIC, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL DIALYZER MARKET SIZE, BY SYNTHETIC, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 33. GLOBAL DIALYZER MARKET SIZE, BY POLYAMIDE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL DIALYZER MARKET SIZE, BY POLYAMIDE, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 35. GLOBAL DIALYZER MARKET SIZE, BY POLYETHERSULFONE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL DIALYZER MARKET SIZE, BY POLYETHERSULFONE, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 37. GLOBAL DIALYZER MARKET SIZE, BY POLYSULFONE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL DIALYZER MARKET SIZE, BY POLYSULFONE, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 39. GLOBAL DIALYZER MARKET SIZE, BY SYNTHETIC, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL DIALYZER MARKET SIZE, BY SYNTHETIC, 2025-2030 (USD MILLION)
  • TABLE 41. GLOBAL DIALYZER MARKET SIZE, BY STERILIZATION METHOD, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL DIALYZER MARKET SIZE, BY STERILIZATION METHOD, 2025-2030 (USD MILLION)
  • TABLE 43. GLOBAL DIALYZER MARKET SIZE, BY ELECTRON BEAM, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL DIALYZER MARKET SIZE, BY ELECTRON BEAM, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 45. GLOBAL DIALYZER MARKET SIZE, BY ETHYLENE OXIDE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL DIALYZER MARKET SIZE, BY ETHYLENE OXIDE, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 47. GLOBAL DIALYZER MARKET SIZE, BY GAMMA IRRADIATION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL DIALYZER MARKET SIZE, BY GAMMA IRRADIATION, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 49. GLOBAL DIALYZER MARKET SIZE, BY STEAM, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL DIALYZER MARKET SIZE, BY STEAM, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 51. GLOBAL DIALYZER MARKET SIZE, BY DISEASE TYPE, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL DIALYZER MARKET SIZE, BY DISEASE TYPE, 2025-2030 (USD MILLION)
  • TABLE 53. GLOBAL DIALYZER MARKET SIZE, BY ACUTE KIDNEY INJURY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL DIALYZER MARKET SIZE, BY ACUTE KIDNEY INJURY, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 55. GLOBAL DIALYZER MARKET SIZE, BY CHRONIC KIDNEY DISEASE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL DIALYZER MARKET SIZE, BY CHRONIC KIDNEY DISEASE, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 57. GLOBAL DIALYZER MARKET SIZE, BY PATIENT GROUP, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL DIALYZER MARKET SIZE, BY PATIENT GROUP, 2025-2030 (USD MILLION)
  • TABLE 59. GLOBAL DIALYZER MARKET SIZE, BY ADULT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL DIALYZER MARKET SIZE, BY ADULT, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 61. GLOBAL DIALYZER MARKET SIZE, BY GERIATRIC, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL DIALYZER MARKET SIZE, BY GERIATRIC, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 63. GLOBAL DIALYZER MARKET SIZE, BY PEDIATRIC, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL DIALYZER MARKET SIZE, BY PEDIATRIC, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 65. GLOBAL DIALYZER MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL DIALYZER MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 67. GLOBAL DIALYZER MARKET SIZE, BY HEMODIAFILTRATION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL DIALYZER MARKET SIZE, BY HEMODIAFILTRATION, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 69. GLOBAL DIALYZER MARKET SIZE, BY HEMODIALYSIS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL DIALYZER MARKET SIZE, BY HEMODIALYSIS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 71. GLOBAL DIALYZER MARKET SIZE, BY HEMOFILTRATION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL DIALYZER MARKET SIZE, BY HEMOFILTRATION, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 73. GLOBAL DIALYZER MARKET SIZE, BY PERITONEAL DIALYSIS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL DIALYZER MARKET SIZE, BY PERITONEAL DIALYSIS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 75. GLOBAL DIALYZER MARKET SIZE, BY PLASMAPHERESIS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL DIALYZER MARKET SIZE, BY PLASMAPHERESIS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 77. GLOBAL DIALYZER MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL DIALYZER MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 79. GLOBAL DIALYZER MARKET SIZE, BY DIALYSIS CENTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL DIALYZER MARKET SIZE, BY DIALYSIS CENTERS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 81. GLOBAL DIALYZER MARKET SIZE, BY HOME CARE SETTINGS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL DIALYZER MARKET SIZE, BY HOME CARE SETTINGS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 83. GLOBAL DIALYZER MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL DIALYZER MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 85. GLOBAL DIALYZER MARKET SIZE, BY SALES CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL DIALYZER MARKET SIZE, BY SALES CHANNEL, 2025-2030 (USD MILLION)
  • TABLE 87. GLOBAL DIALYZER MARKET SIZE, BY OFFLINE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL DIALYZER MARKET SIZE, BY OFFLINE, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 89. GLOBAL DIALYZER MARKET SIZE, BY ONLINE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL DIALYZER MARKET SIZE, BY ONLINE, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 91. AMERICAS DIALYZER MARKET SIZE, BY REUSE TYPE, 2018-2024 (USD MILLION)
  • TABLE 92. AMERICAS DIALYZER MARKET SIZE, BY REUSE TYPE, 2025-2030 (USD MILLION)
  • TABLE 93. AMERICAS DIALYZER MARKET SIZE, BY FLUX TYPE, 2018-2024 (USD MILLION)
  • TABLE 94. AMERICAS DIALYZER MARKET SIZE, BY FLUX TYPE, 2025-2030 (USD MILLION)
  • TABLE 95. AMERICAS DIALYZER MARKET SIZE, BY MEMBRANE MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 96. AMERICAS DIALYZER MARKET SIZE, BY MEMBRANE MATERIAL, 2025-2030 (USD MILLION)
  • TABLE 97. AMERICAS DIALYZER MARKET SIZE, BY CELLULOSE, 2018-2024 (USD MILLION)
  • TABLE 98. AMERICAS DIALYZER MARKET SIZE, BY CELLULOSE, 2025-2030 (USD MILLION)
  • TABLE 99. AMERICAS DIALYZER MARKET SIZE, BY SYNTHETIC, 2018-2024 (USD MILLION)
  • TABLE 100. AMERICAS DIALYZER MARKET SIZE, BY SYNTHETIC, 2025-2030 (USD MILLION)
  • TABLE 101. AMERICAS DIALYZER MARKET SIZE, BY STERILIZATION METHOD, 2018-2024 (USD MILLION)
  • TABLE 102. AMERICAS DIALYZER MARKET SIZE, BY STERILIZATION METHOD, 2025-2030 (USD MILLION)
  • TABLE 103. AMERICAS DIALYZER MARKET SIZE, BY DISEASE TYPE, 2018-2024 (USD MILLION)
  • TABLE 104. AMERICAS DIALYZER MARKET SIZE, BY DISEASE TYPE, 2025-2030 (USD MILLION)
  • TABLE 105. AMERICAS DIALYZER MARKET SIZE, BY PATIENT GROUP, 2018-2024 (USD MILLION)
  • TABLE 106. AMERICAS DIALYZER MARKET SIZE, BY PATIENT GROUP, 2025-2030 (USD MILLION)
  • TABLE 107. AMERICAS DIALYZER MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 108. AMERICAS DIALYZER MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 109. AMERICAS DIALYZER MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 110. AMERICAS DIALYZER MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 111. AMERICAS DIALYZER MARKET SIZE, BY SALES CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 112. AMERICAS DIALYZER MARKET SIZE, BY SALES CHANNEL, 2025-2030 (USD MILLION)
  • TABLE 113. AMERICAS DIALYZER MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 114. AMERICAS DIALYZER MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
  • TABLE 115. UNITED STATES DIALYZER MARKET SIZE, BY REUSE TYPE, 2018-2024 (USD MILLION)
  • TABLE 116. UNITED STATES DIALYZER MARKET SIZE, BY REUSE TYPE, 2025-2030 (USD MILLION)
  • TABLE 117. UNITED STATES DIALYZER MARKET SIZE, BY FLUX TYPE, 2018-2024 (USD MILLION)
  • TABLE 118. UNITED STATES DIALYZER MARKET SIZE, BY FLUX TYPE, 2025-2030 (USD MILLION)
  • TABLE 119. UNITED STATES DIALYZER MARKET SIZE, BY MEMBRANE MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 120. UNITED STATES DIALYZER MARKET SIZE, BY MEMBRANE MATERIAL, 2025-2030 (USD MILLION)
  • TABLE 121. UNITED STATES DIALYZER MARKET SIZE, BY CELLULOSE, 2018-2024 (USD MILLION)
  • TABLE 122. UNITED STATES DIALYZER MARKET SIZE, BY CELLULOSE, 2025-2030 (USD MILLION)
  • TABLE 123. UNITED STATES DIALYZER MARKET SIZE, BY SYNTHETIC, 2018-2024 (USD MILLION)
  • TABLE 124. UNITED STATES DIALYZER MARKET SIZE, BY SYNTHETIC, 2025-2030 (USD MILLION)
  • TABLE 125. UNITED STATES DIALYZER MARKET SIZE, BY STERILIZATION METHOD, 2018-2024 (USD MILLION)
  • TABLE 126. UNITED STATES DIALYZER MARKET SIZE, BY STERILIZATION METHOD, 2025-2030 (USD MILLION)
  • TABLE 127. UNITED STATES DIALYZER MARKET SIZE, BY DISEASE TYPE, 2018-2024 (USD MILLION)
  • TABLE 128. UNITED STATES DIALYZER MARKET SIZE, BY DISEASE TYPE, 2025-2030 (USD MILLION)
  • TABLE 129. UNITED STATES DIALYZER MARKET SIZE, BY PATIENT GROUP, 2018-2024 (USD MILLION)
  • TABLE 130. UNITED STATES DIALYZER MARKET SIZE, BY PATIENT GROUP, 2025-2030 (USD MILLION)
  • TABLE 131. UNITED STATES DIALYZER MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 132. UNITED STATES DIALYZER MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 133. UNITED STATES DIALYZER MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 134. UNITED STATES DIALYZER MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 135. UNITED STATES DIALYZER MARKET SIZE, BY SALES CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 136. UNITED STATES DIALYZER MARKET SIZE, BY SALES CHANNEL, 2025-2030 (USD MILLION)
  • TABLE 137. UNITED STATES DIALYZER MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
  • TABLE 138. UNITED STATES DIALYZER MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
  • TABLE 139. CANADA DIALYZER MARKET SIZE, BY REUSE TYPE, 2018-2024 (USD MILLION)
  • TABLE 140. CANADA DIALYZER MARKET SIZE, BY REUSE TYPE, 2025-2030 (USD MILLION)
  • TABLE 141. CANADA DIALYZER MARKET SIZE, BY FLUX TYPE, 2018-2024 (USD MILLION)
  • TABLE 142. CANADA DIALYZER MARKET SIZE, BY FLUX TYPE, 2025-2030 (USD MILLION)
  • TABLE 143. CANADA DIALYZER MARKET SIZE, BY MEMBRANE MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 144. CANADA DIALYZER MARKET SIZE, BY MEMBRANE MATERIAL, 2025-2030 (USD MILLION)
  • TABLE 145. CANADA DIALYZER MARKET SIZE, BY CELLULOSE, 2018-2024 (USD MILLION)
  • TABLE 146. CANADA DIALYZER MARKET SIZE, BY CELLULOSE, 2025-2030 (USD MILLION)
  • TABLE 147. CANADA DIALYZER MARKET SIZE, BY SYNTHETIC, 2018-2024 (USD MILLION)
  • TABLE 148. CANADA DIALYZER MARKET SIZE, BY SYNTHETIC, 2025-2030 (USD MILLION)
  • TABLE 149. CANADA DIALYZER MARKET SIZE, BY STERILIZATION METHOD, 2018-2024 (USD MILLION)
  • TABLE 150. CANADA DIALYZER MARKET SIZE, BY STERILIZATION METHOD, 2025-2030 (USD MILLION)
  • TABLE 151. CANADA DIALYZER MARKET SIZE, BY DISEASE TYPE, 2018-2024 (USD MILLION)
  • TABLE 152. CANADA DIALYZER MARKET SIZE, BY DISEASE TYPE, 2025-2030 (USD MILLION)
  • TABLE 153. CANADA DIALYZER MARKET SIZE, BY PATIENT GROUP, 2018-2024 (USD MILLION)
  • TABLE 154. CANADA DIALYZER MARKET SIZE, BY PATIENT GROUP, 2025-2030 (USD MILLION)
  • TABLE 155. CANADA DIALYZER MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 156. CANADA DIALYZER MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 157. CANADA DIALYZER MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 158. CANADA DIALYZER MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 159. CANADA DIALYZER MARKET SIZE, BY SALES CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 160. CANADA DIALYZER MARKET SIZE, BY SALES CHANNEL, 2025-2030 (USD MILLION)
  • TABLE 161. MEXICO DIALYZER MARKET SIZE, BY REUSE TYPE, 2018-2024 (USD MILLION)
  • TABLE 162. MEXICO DIALYZER MARKET SIZE, BY REUSE TYPE, 2025-2030 (USD MILLION)
  • TABLE 163. MEXICO DIALYZER MARKET SIZE, BY FLUX TYPE, 2018-2024 (USD MILLION)
  • TABLE 164. MEXICO DIALYZER MARKET SIZE, BY FLUX TYPE, 2025-2030 (USD MILLION)
  • TABLE 165. MEXICO DIALYZER MARKET SIZE, BY MEMBRANE MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 166. MEXICO DIALYZER MARKET SIZE, BY MEMBRANE MATERIAL, 2025-2030 (USD MILLION)
  • TABLE 167. MEXICO DIALYZER MARKET SIZE, BY CELLULOSE, 2018-2024 (USD MILLION)
  • TABLE 168. MEXICO DIALYZER MARKET SIZE, BY CELLULOSE, 2025-2030 (USD MILLION)
  • TABLE 169. MEXICO DIALYZER MARKET SIZE, BY SYNTHETIC, 2018-2024 (USD MILLION)
  • TABLE 170. MEXICO DIALYZER MARKET SIZE, BY SYNTHETIC, 2025-2030 (USD MILLION)
  • TABLE 171. MEXICO DIALYZER MARKET SIZE, BY STERILIZATION METHOD, 2018-2024 (USD MILLION)
  • TABLE 172. MEXICO DIALYZER MARKET SIZE, BY STERILIZATION METHOD, 2025-2030 (USD MILLION)
  • TABLE 173. MEXICO DIALYZER MARKET SIZE, BY DISEASE TYPE, 2018-2024 (USD MILLION)
  • TABLE 174. MEXICO DIALYZER MARKET SIZE, BY DISEASE TYPE, 2025-2030 (USD MILLION)
  • TABLE 175. MEXICO DIALYZER MARKET SIZE, BY PATIENT GROUP, 2018-2024 (USD MILLION)
  • TABLE 176. MEXICO DIALYZER MARKET SIZE, BY PATIENT GROUP, 2025-2030 (USD MILLION)
  • TABLE 177. MEXICO DIALYZER MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 178. MEXICO DIALYZER MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 179. MEXICO DIALYZER MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 180. MEXICO DIALYZER MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 181. MEXICO DIALYZER MARKET SIZE, BY SALES CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 182. MEXICO DIALYZER MARKET SIZE, BY SALES CHANNEL, 2025-2030 (USD MILLION)
  • TABLE 183. BRAZIL DIALYZER MARKET SIZE, BY REUSE TYPE, 2018-2024 (USD MILLION)
  • TABLE 184. BRAZIL DIALYZER MARKET SIZE, BY REUSE TYPE, 2025-2030 (USD MILLION)
  • TABLE 185. BRAZIL DIALYZER MARKET SIZE, BY FLUX TYPE, 2018-2024 (USD MILLION)
  • TABLE 186. BRAZIL DIALYZER MARKET SIZE, BY FLUX TYPE, 2025-2030 (USD MILLION)
  • TABLE 187. BRAZIL DIALYZER MARKET SIZE, BY MEMBRANE MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 188. BRAZIL DIALYZER MARKET SIZE, BY MEMBRANE MATERIAL, 2025-2030 (USD MILLION)
  • TABLE 189. BRAZIL DIALYZER MARKET SIZE, BY CELLULOSE, 2018-2024 (USD MILLION)
  • TABLE 190. BRAZIL DIALYZER MARKET SIZE, BY CELLULOSE, 2025-2030 (USD MILLION)
  • TABLE 191. BRAZIL DIALYZER MARKET SIZE, BY SYNTHETIC, 2018-2024 (USD MILLION)
  • TABLE 192. BRAZIL DIALYZER MARKET SIZE, BY SYNTHETIC, 2025-2030 (USD MILLION)
  • TABLE 193. BRAZIL DIALYZER MARKET SIZE, BY STERILIZATION METHOD, 2018-2024 (USD MILLION)
  • TABLE 194. BRAZIL DIALYZER MARKET SIZE, BY STERILIZATION METHOD, 2025-2030 (USD MILLION)
  • TABLE 195. BRAZIL DIALYZER MARKET SIZE, BY DISEASE TYPE, 2018-2024 (USD MILLION)
  • TABLE 196. BRAZIL DIALYZER MARKET SIZE, BY DISEASE TYPE, 2025-2030 (USD MILLION)
  • TABLE 197. BRAZIL DIALYZER MARKET SIZE, BY PATIENT GROUP, 2018-2024 (USD MILLION)
  • TABLE 198. BRAZIL DIALYZER MARKET SIZE, BY PATIENT GROUP, 2025-2030 (USD MILLION)
  • TABLE 199. BRAZIL DIALYZER MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 200. BRAZIL DIALYZER MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 201. BRAZIL DIALYZER MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 202. BRAZIL DIALYZER MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 203. BRAZIL DIALYZER MARKET SIZE, BY SALES CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 204. BRAZIL DIALYZER MARKET SIZE, BY SALES CHANNEL, 2025-2030 (USD MILLION)
  • TABLE 205. ARGENTINA DIALYZER MARKET SIZE, BY REUSE TYPE, 2018-2024 (USD MILLION)
  • TABLE 206. ARGENTINA DIALYZER MARKET SIZE, BY REUSE TYPE, 2025-2030 (USD MILLION)
  • TABLE 207. ARGENTINA DIALYZER MARKET SIZE, BY FLUX TYPE, 2018-2024 (USD MILLION)
  • TABLE 208. ARGENTINA DIALYZER MARKET SIZE, BY FLUX TYPE, 2025-2030 (USD MILLION)
  • TABLE 209. ARGENTINA DIALYZER MARKET SIZE, BY MEMBRANE MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 210. ARGENTINA DIALYZER MARKET SIZE, BY MEMBRANE MATERIAL, 2025-2030 (USD MILLION)
  • TABLE 211. ARGENTINA DIALYZER MARKET SIZE, BY CELLULOSE, 2018-2024 (USD MILLION)
  • TABLE 212. ARGENTINA DIALYZER MARKET SIZE, BY CELLULOSE, 2025-2030 (USD MILLION)
  • TABLE 213. ARGENTINA DIALYZER MARKET SIZE, BY SYNTHETIC, 2018-2024 (USD MILLION)
  • TABLE 214. ARGENTINA DIALYZER MARKET SIZE, BY SYNTHETIC, 2025-2030 (USD MILLION)
  • TABLE 215. ARGENTINA DIALYZER MARKET SIZE, BY STERILIZATION METHOD, 2018-2024 (USD MILLION)
  • TABLE 216. ARGENTINA DIALYZER MARKET SIZE, BY STERILIZATION METHOD, 2025-2030 (USD MILLION)
  • TABLE 217. ARGENTINA DIALYZER MARKET SIZE, BY DISEASE TYPE, 2018-2024 (USD MILLION)
  • TABLE 218. ARGENTINA DIALYZER MARKET SIZE, BY DISEASE TYPE, 2025-2030 (USD MILLION)
  • TABLE 219. ARGENTINA DIALYZER MARKET SIZE, BY PATIENT GROUP, 2018-2024 (USD MILLION)
  • TABLE 220. ARGENTINA DIALYZER MARKET SIZE, BY PATIENT GROUP, 2025-2030 (USD MILLION)
  • TABLE 221. ARGENTINA DIALYZER MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 222. ARGENTINA DIALYZER MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 223. ARGENTINA DIALYZER MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 224. ARGENTINA DIALYZER MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 225. ARGENTINA DIALYZER MARKET SIZE, BY SALES CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 226. ARGENTINA DIALYZER MARKET SIZE, BY SALES CHANNEL, 2025-2030 (USD MILLION)
  • TABLE 227. EUROPE, MIDDLE EAST & AFRICA DIALYZER MARKET SIZE, BY REUSE TYPE, 2018-2024 (USD MILLION)
  • TABLE 228. EUROPE, MIDDLE EAST & AFRICA DIALYZER MARKET SIZE, BY REUSE TYPE, 2025-2030 (USD MILLION)
  • TABLE 229. EUROPE, MIDDLE EAST & AFRICA DIALYZER MARKET SIZE, BY FLUX TYPE, 2018-2024 (USD MILLION)
  • TABLE 230. EUROPE, MIDDLE EAST & AFRICA DIALYZER MARKET SIZE, BY FLUX TYPE, 2025-2030 (USD MILLION)
  • TABLE 231. EUROPE, MIDDLE EAST & AFRICA DIALYZER MARKET SIZE, BY MEMBRANE MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 232. EUROPE, MIDDLE EAST & AFRICA DIALYZER MARKET SIZE, BY MEMBRANE MATERIAL, 2025-2030 (USD MILLION)
  • TABLE 233. EUROPE, MIDDLE EAST & AFRICA DIALYZER MARKET SIZE, BY CELLULOSE, 2018-2024 (USD MILLION)
  • TABLE 234. EUROPE, MIDDLE EAST & AFRICA DIALYZER MARKET SIZE, BY CELLULOSE, 2025-2030 (USD MILLION)
  • TABLE 235. EUROPE, MIDDLE EAST & AFRICA DIALYZER MARKET SIZE, BY SYNTHETIC, 2018-2024 (USD MILLION)
  • TABLE 236. EUROPE, MIDDLE EAST & AFRICA DIALYZER MARKET SIZE, BY SYNTHETIC, 2025-2030 (USD MILLION)
  • TABLE 237. EUROPE, MIDDLE EAST & AFRICA DIALYZER MARKET SIZE, BY STERILIZATION METHOD, 2018-2024 (USD MILLION)
  • TABLE 238. EUROPE, MIDDLE EAST & AFRICA DIALYZER MARKET SIZE, BY STERILIZATION METHOD, 2025-2030 (USD MILLION)
  • TABLE 239. EUROPE, MIDDLE EAST & AFRICA DIALYZER MARKET SIZE, BY DISEASE TYPE, 2018-2024 (USD MILLION)
  • TABLE 240. EUROPE, MIDDLE EAST & AFRICA DIALYZER MARKET SIZE, BY DISEASE TYPE, 2025-2030 (USD MILLION)
  • TABLE 241. EUROPE, MIDDLE EAST & AFRICA DIALYZER MARKET SIZE, BY PATIENT GROUP, 2018-2024 (USD MILLION)
  • TABLE 242. EUROPE, MIDDLE EAST & AFRICA DIALYZER MARKET SIZE, BY PATIENT GROUP, 2025-2030 (USD MILLION)
  • TABLE 243. EUROPE, MIDDLE EAST & AFRICA DIALYZER MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 244. EUROPE, MIDDLE EAST & AFRICA DIALYZER MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 245. EUROPE, MIDDLE EAST & AFRICA DIALYZER MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 246. EUROPE, MIDDLE EAST & AFRICA DIALYZER MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 247. EUROPE, MIDDLE EAST & AFRICA DIALYZER MARKET SIZE, BY SALES CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 248. EUROPE, MIDDLE EAST & AFRICA DIALYZER MARKET SIZE, BY SALES CHANNEL, 2025-2030 (USD MILLION)
  • TABLE 249. EUROPE, MIDDLE EAST & AFRICA DIALYZER MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 250. EUROPE, MIDDLE EAST & AFRICA DIALYZER MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
  • TABLE 251. UNITED KINGDOM DIALYZER MARKET SIZE, BY REUSE TYPE, 2018-2024 (USD MILLION)
  • TABLE 252. UNITED KINGDOM DIALYZER MARKET SIZE, BY REUSE TYPE, 2025-2030 (USD MILLION)
  • TABLE 253. UNITED KINGDOM DIALYZER MARKET SIZE, BY FLUX TYPE, 2018-2024 (USD MILLION)
  • TABLE 254. UNITED KINGDOM DIALYZER MARKET SIZE, BY FLUX TYPE, 2025-2030 (USD MILLION)
  • TABLE 255. UNITED KINGDOM DIALYZER MARKET SIZE, BY MEMBRANE MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 256. UNITED KINGDOM DIALYZER MARKET SIZE, BY MEMBRANE MATERIAL, 2025-2030 (USD MILLION)
  • TABLE 257. UNITED KINGDOM DIALYZER MARKET SIZE, BY CELLULOSE, 2018-2024 (USD MILLION)
  • TABLE 258. UNITED KINGDOM DIALYZER MARKET SIZE, BY CELLULOSE, 2025-2030 (USD MILLION)
  • TABLE 259. UNITED KINGDOM DIALYZER MARKET SIZE, BY SYNTHETIC, 2018-2024 (USD MILLION)
  • TABLE 260. UNITED KINGDOM DIALYZER MARKET SIZE, BY SYNTHETIC, 2025-2030 (USD MILLION)
  • TABLE 261. UNITED KINGDOM DIALYZER MARKET SIZE, BY STERILIZATION METHOD, 2018-2024 (USD MILLION)
  • TABLE 262. UNITED KINGDOM DIALYZER MARKET SIZE, BY STERILIZATION METHOD, 2025-2030 (USD MILLION)
  • TABLE 263. UNITED KINGDOM DIALYZER MARKET SIZE, BY DISEASE TYPE, 2018-2024 (USD MILLION)
  • TABLE 264. UNITED KINGDOM DIALYZER MARKET SIZE, BY DISEASE TYPE, 2025-2030 (USD MILLION)
  • TABLE 265. UNITED KINGDOM DIALYZER MARKET SIZE, BY PATIENT GROUP, 2018-2024 (USD MILLION)
  • TABLE 266. UNITED KINGDOM DIALYZER MARKET SIZE, BY PATIENT GROUP, 2025-2030 (USD MILLION)
  • TABLE 267. UNITED KINGDOM DIALYZER MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 268. UNITED KINGDOM DIALYZER MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 269. UNITED KINGDOM DIALYZER MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 270. UNITED KINGDOM DIALYZER MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 271. UNITED KINGDOM DIALYZER MARKET SIZE, BY SALES CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 272. UNITED KINGDOM DIALYZER MARKET SIZE, BY SALES CHANNEL, 2025-2030 (USD MILLION)
  • TABLE 273. GERMANY DIALYZER MARKET SIZE, BY REUSE TYPE, 2018-2024 (USD MILLION)
  • TABLE 274. GERMANY DIALYZER MARKET SIZE, BY REUSE TYPE, 2025-2030 (USD MILLION)
  • TABLE 275. GERMANY DIALYZER MARKET SIZE, BY FLUX TYPE, 2018-2024 (USD MILLION)
  • TABLE 276. GERMANY DIALYZER MARKET SIZE, BY FLUX TYPE, 2025-2030 (USD MILLION)
  • TABLE 277. GERMANY DIALYZER MARKET SIZE, BY MEMBRANE MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 278. GERMANY DIALYZER MARKET SIZE, BY MEMBRANE MATERIAL, 2025-2030 (USD MILLION)
  • TABLE 279. GERMANY DIALYZER MARKET SIZE, BY CELLULOSE, 2018-2024 (USD MILLION)
  • TABLE 280. GERMANY DIALYZER MARKET SIZE, BY CELLULOSE, 2025-2030 (USD MILLION)
  • TABLE 281. GERMANY DIALYZER MARKET SIZE, BY SYNTHETIC, 2018-2024 (USD MILLION)
  • TABLE 282. GERMANY DIALYZER MARKET SIZE, BY SYNTHETIC, 2025-2030 (USD MILLION)
  • TABLE 283. GERMANY DIALYZER MARKET SIZE, BY STERILIZATION METHOD, 2018-2024 (USD MILLION)
  • TABLE 284. GERMANY DIALYZER MARKET SIZE, BY STERILIZATION METHOD, 2025-2030 (USD MILLION)
  • TABLE 285. GERMANY DIALYZER MARKET SIZE, BY DISEASE TYPE, 2018-2024 (USD MILLION)
  • TABLE 286. GERMANY DIALYZER MARKET SIZE, BY DISEASE TYPE, 2025-2030 (USD MILLION)
  • TABLE 287. GERMANY DIALYZER MARKET SIZE, BY PATIENT GROUP, 2018-2024 (USD MILLION)
  • TABLE 288. GERMANY DIALYZER MARKET SIZE, BY PATIENT GROUP, 2025-2030 (USD MILLION)
  • TABLE 289. GERMANY DIALYZER MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 290. GERMANY DIALYZER MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 291. GERMANY DIALYZER MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 292. GERMANY DIALYZER MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 293. GERMANY DIALYZER MARKET SIZE, BY SALES CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 294. GERMANY DIALYZER MARKET SIZE, BY SALES CHANNEL, 2025-2030 (USD MILLION)
  • TABLE 295. FRANCE DIALYZER MARKET SIZE, BY REUSE TYPE, 2018-2024 (USD MILLION)
  • TABLE 296. FRANCE DIALYZER MARKET SIZE, BY REUSE TYPE, 2025-2030 (USD MILLION)
  • TABLE 297. FRANCE DIALYZER MARKET SIZE, BY FLUX TYPE, 2018-2024 (USD MILLION)
  • TABLE 298. FRANCE DIALYZER MARKET SIZE, BY FLUX TYPE, 2025-2030 (USD MILLION)
  • TABLE 299. FRANCE DIALYZER MARKET SIZE, BY MEMBRANE MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 300. FRANCE DIALYZER MARKET SIZE, BY MEMBRANE MATERIAL, 2025-2030 (USD MILLION)
  • TABLE 301. FRANCE DIALYZER MARKET SIZE, BY CELLULOSE, 2018-2024 (USD MILLION)
  • TABLE 302. FRANCE DIALYZER MARKET SIZE, BY CELLULOSE, 2025-2030 (USD MILLION)
  • TABLE 303. FRANCE DIALYZER MARKET SIZE, BY SYNTHETIC, 2018-2024 (USD MILLION)
  • TABLE 304. FRANCE DIALYZER MARKET SIZE, BY SYNTHETIC, 2025-2030 (USD MILLION)
  • TABLE 305. FRANCE DIALYZER MARKET SIZE, BY STERILIZATION METHOD, 2018-2024 (USD MILLION)
  • TABLE 306. FRANCE DIALYZER MARKET SIZE, BY STERILIZATION METHOD, 2025-2030 (USD MILLION)
  • TABLE 307. FRANCE DIALYZER MARKET SIZE, BY DISEASE TYPE, 2018-2024 (USD MILLION)
  • TABLE 308. FRANCE DIALYZER MARKET SIZE, BY DISEASE TYPE, 2025-2030 (USD MILLION)
  • TABLE 309. FRANCE DIALYZER MARKET SIZE, BY PATIENT GROUP, 2018-2024 (USD MILLION)
  • TABLE 310. FRANCE DIALYZER MARKET SIZE, BY PATIENT GROUP, 2025-2030 (USD MILLION)
  • TABLE 311. FRANCE DIALYZER MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 312. FRANCE DIALYZER MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 313. FRANCE DIALYZER MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 314. FRANCE DIALYZER MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 315. FRANCE DIALYZER MARKET SIZE, BY SALES CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 316. FRANCE DIALYZER MARKET SIZE, BY SALES CHANNEL, 2025-2030 (USD MILLION)
  • TABLE 317. RUSSIA DIALYZER MARKET SIZE, BY REUSE TYPE, 2018-2024 (USD MILLION)
  • TABLE 318. RUSSIA DIALYZER MARKET SIZE, BY REUSE TYPE, 2025-2030 (USD MILLION)
  • TABLE 319. RUSSIA DIALYZER MARKET SIZE, BY FLUX TYPE, 2018-2024 (USD MILLION)
  • TABLE 320. RUSSIA DIALYZER MARKET SIZE, BY FLUX TYPE, 2025-2030 (USD MILLION)
  • TABLE 321. RUSSIA DIALYZER MARKET SIZE, BY MEMBRANE MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 322. RUSSIA DIALYZER MARKET SIZE, BY MEMBRANE MATERIAL, 2025-2030 (USD MILLION)
  • TABLE 323. RUSSIA DIALYZER MARKET SIZE, BY CELLULOSE, 2018-2024 (USD MILLION)
  • TABLE 324. RUSSIA DIALYZER MARKET SIZE, BY CELLULOSE, 2025-2030 (USD MILLION)
  • TABLE 325. RUSSIA DIALYZER MARKET SIZE, BY SYNTHETIC, 2018-2024 (USD MILLION)
  • TABLE 326. RUSSIA DIALYZER MARKET SIZE, BY SYNTHETIC, 2025-2030 (USD MILLION)
  • TABLE 327. RUSSIA DIALYZER MARKET SIZE, BY STERILIZATION METHOD, 2018-2024 (USD MILLION)
  • TABLE 328. RUSSIA DIALYZER MARKET SIZE, BY STERILIZATION METHOD, 2025-2030 (USD MILLION)
  • TABLE 329. RUSSIA DIALYZER MARKET SIZE, BY DISEASE TYPE, 2018-2024 (USD MILLION)
  • TABLE 330. RUSSIA DIALYZER MARKET SIZE, BY DISEASE TYPE, 2025-2030 (USD MILLION)
  • TABLE 331. RUSSIA DIALYZER MARKET SIZE, BY PATIENT GROUP, 2018-2024 (USD MILLION)
  • TABLE 332. RUSSIA DIALYZER MARKET SIZE, BY PATIENT GROUP, 2025-2030 (USD MILLION)
  • TABLE 333. RUSSIA DIALYZER MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 334. RUSSIA DIALYZER MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 335. RUSSIA DIALYZER MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 336. RUSSIA DIALYZER MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 337. RUSSIA DIALYZER MARKET SIZE, BY SALES CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 338. RUSSIA DIALYZER MARKET SIZE, BY SALES CHANNEL, 2025-2030 (USD MILLION)
  • TABLE 339. ITALY DIALYZER MARKET SIZE, BY REUSE TYPE, 2018-2024 (USD MILLION)
  • TABLE 340. ITALY DIALYZER MARKET SIZE, BY REUSE TYPE, 2025-2030 (USD MILLION)
  • TABLE 341. ITALY DIALYZER MARKET SIZE, BY FLUX TYPE, 2018-2024 (USD MILLION)
  • TABLE 342. ITALY DIALYZER MARKET SIZE, BY FLUX TYPE, 2025-2030 (USD MILLION)
  • TABLE 343. ITALY DIALYZER MARKET SIZE, BY MEMBRANE MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 344. ITALY DIALYZER MARKET SIZE, BY MEMBRANE MATERIAL, 2025-2030 (USD MILLION)
  • TABLE 345. ITALY DIALYZER MARKET SIZE, BY CELLULOSE, 2018-2024 (USD MILLION)
  • TABLE 346. ITALY DIALYZER MARKET SIZE, BY CELLULOSE, 2025-2030 (USD MILLION)
  • TABLE 347. ITALY DIALYZER MARKET SIZE, BY SYNTHETIC, 2018-2024 (USD MILLION)
  • TABLE 348. ITALY DIALYZER MARKET SIZE, BY SYNTHETIC, 2025-2030 (USD MILLION)
  • TABLE 349. ITALY DIALYZER MARKET SIZE, BY STERILIZATION METHOD, 2018-2024 (USD MILLION)
  • TABLE 350. ITALY DIALYZER MARKET SIZE, BY STERILIZATION METHOD, 2025-2030 (USD MILLION)
  • TABLE 351. ITALY DIALYZER MARKET SIZE, BY DISEASE TYPE, 2018-2024 (USD MILLION)
  • TABLE 352. ITALY DIALYZER MARKET SIZE, BY DISEASE TYPE, 2025-2030 (USD MILLION)
  • TABLE 353. ITALY DIALYZER MARKET SIZE, BY PATIENT GROUP, 2018-2024 (USD MILLION)
  • TABLE 354. ITALY DIALYZER MARKET SIZE, BY PATIENT GROUP, 2025-2030 (USD MILLION)
  • TABLE 355. ITALY DIALYZER MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 356. ITALY DIALYZER MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 357. ITALY DIALYZER MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 358. ITALY DIALYZER MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 359. ITALY DIALYZER MARKET SIZE, BY SALES CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 360. ITALY DIALYZER MARKET SIZE, BY SALES CHANNEL, 2025-2030 (USD MILLION)
  • TABLE 361. SPAIN DIALYZER MARKET SIZE, BY REUSE TYPE, 2018-2024 (USD MILLION)
  • TABLE 362. SPAIN DIALYZER MARKET SIZE, BY REUSE TYPE, 2025-2030 (USD MILLION)
  • TABLE 363. SPAIN DIALYZER MARKET SIZE, BY FLUX TYPE, 2018-2024 (USD MILLION)
  • TABLE 364. SPAIN DIALYZER MARKET SIZE, BY FLUX TYPE, 2025-2030 (USD MILLION)
  • TABLE 365. SPAIN DIALYZER MARKET SIZE, BY MEMBRANE MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 366. SPAIN DIALYZER MARKET SIZE, BY MEMBRANE MATERIAL, 2025-2030 (USD MILLION)
  • TABLE 367. SPAIN DIALYZER MARKET SIZE, BY CELLULOSE, 2018-2024 (USD MILLION)
  • TABLE 368. SPAIN DIALYZER MARKET SIZE, BY CELLULOSE, 2025-2030 (USD MILLION)
  • TABLE 369. SPAIN DIALYZER MARKET SIZE, BY SYNTHETIC, 2018-2024 (USD MILLION)
  • TABLE 370. SPAIN DIALYZER MARKET SIZE, BY SYNTHETIC, 2025-2030 (USD MILLION)
  • TABLE 371. SPAIN DIALYZER MARKET SIZE, BY STERILIZATION METHOD, 2018-2024 (USD MILLION)
  • TABLE 372. SPAIN DIALYZER MARKET SIZE, BY STERILIZATION METHOD, 2025-2030 (USD MILLION)
  • TABLE 373. SPAIN DIALYZER MARKET SIZE, BY DISEASE TYPE, 2018-2024 (USD MILLION)
  • TABLE 374. SPAIN DIALYZER MARKET SIZE, BY DISEASE TYPE, 2025-2030 (USD MILLION)
  • TABLE 375. SPAIN DIALYZER MARKET SIZE, BY PATIENT GROUP, 2018-2024 (USD MILLION)
  • TABLE 376. SPAIN DIALYZER MARKET SIZE, BY PATIENT GROUP, 2025-2030 (USD MILLION)
  • TABLE 377. SPAIN DIALYZER MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 378. SPAIN DIALYZER MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 379. SPAIN DIALYZER MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 380. SPAIN DIALYZER MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 381. SPAIN DIALYZER MARKET SIZE, BY SALES CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 382. SPAIN DIALYZER MARKET SIZE, BY SALES CHANNEL, 2025-2030 (USD MILLION)
  • TABLE 383. UNITED ARAB EMIRATES DIALYZER MARKET SIZE, BY REUSE TYPE, 2018-2024 (USD MILLION)
  • TABLE 384. UNITED ARAB EMIRATES DIALYZER MARKET SIZE, BY REUSE TYPE, 2025-2030 (USD MILLION)
  • TABLE 385. UNITED ARAB EMIRATES DIALYZER MARKET SIZE, BY FLUX TYPE, 2018-2024 (USD MILLION)
  • TABLE 386. UNITED ARAB EMIRATES DIALYZER MARKET SIZE, BY FLUX TYPE, 2025-2030 (USD MILLION)
  • TABLE 387. UNITED ARAB EMIRATES DIALYZER MARKET SIZE, BY MEMBRANE MATERIAL, 2018-2024